A recombinant human papillomavirus (HPV) type 16 L1-vaccinia virus murine challenge model demonstrates cell-mediated immunity against HPV virus-like particles

Journal of General Virology

Volumn 80, Issue 9, 1999, Pages 2471-2475

  Marais, Dianne ^a   Passmore, Jo Ann ^a   Maclean, James ^a   Rose, Robert ^b   Williamson, Anna Lise ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; IMMUNIZATION; MOUSE; NONHUMAN; OVARY; PRIORITY JOURNAL; VIRUS PARTICLE; VIRUS RECOMBINANT; WART VIRUS;

ANIMALIA; DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; MURINAE; VACCINIA; VACCINIA VIRUS;

EID: 0032839902     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-80-9-2471     Document Type: Article

References (31)

1. Alloub, M. I., Barr, B. B., McLaren, K. M., Smith, I. W., Bunney, M. H. & Smart, G. E. (1989). Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts. British Medical Journal 298, 153-156.
2. Bachmann, M. F., Kundig, T. M., Freer, G., Li, Y., Kang, C. Y., Bishop, D. H., Hengartner, H. & Zinkernagel, R. M. (1994). Induction of protective cytotoxic T cells with viral proteins. European Journal of Immunology 24, 2228-2236.
3. Belyakov, I. M., Derby, M. A., Ahlers, J. D., Kelsall, B. L., Earl, P., Moss, B., Strober, W. & Berzofsky, J. A. (1998). Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge. Proceedings of the National Academy of Sciences, USA 95, 1709-1714.
4. + T cells correlating with cytotoxic activity in vitro are more efficient in antivaccinia virus protection than CD4-dependent IL. Journal of Immunology 146, 4301-4307.
5. Bonnez, W., DaRin, C., Borkhuis, C., de Mesy Jensen, K., Reichman, R. C. & Rose, R. C. (1998). Isolation and propagation of human papillomavirus type 16 in human xenografts implanted in the severe combined immunodeficiency mouse. Journal of Virology 72, 5256-5261.
6. Bosch, F. X., Manos, M. M., Muñoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R. & Shah, K. V. (1995). Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. Journal of the National Cancer Institute 87, 796-802.
7. Boyum, A. (1968). Separation of leukocytes from blood and bone marrow. Introduction. Scandinavian Journal of Clinical and Laboratory Investigation Supplement 97, 7.
8. Breitburd, F., Kirnbauer, R., Hubbert, N. L., Nonnenmacher, B., Trin-Dinh-Desmarquet, C., Orth, G., Schiller, J. T. & Lowy, D. R. (1995). Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. Journal of Virology 69, 3959-3963.
9. Chakrabarti, S., Brechling, K. & Moss, B. (1985). Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Molecular and Cellular Biology 5, 3403-3409.
10. Christensen, N. D., Reed, C. A., Cladel, N. M., Han, R. & Kreider, J. W. (1996). Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus. Journal of Virology 70, 960-965.
11. Coleman, N., Birley, H. D., Renton, A. M., Hanna, N. F., Ryait, B. K., Byrne, M., Taylor-Robinson, D. & Stanley, M. A. (1994). Immunological events in regressing genital warts. American Journal of Clinical Pathology 102, 768-774.
12. De Bruijn, M. L. H., Greenstone, H. L., Vermeulen, H., Melief, C. J. M., Lowy, D. R., Schiller, J. T. & Kast, W. M. (1998). L1-specific protection from tumor challenge elicited by HPV16 virus-like particles. Virology 250, 371-376.
13. Dupuy, C., Buzoni-Gatel, D., Touze, A., Le Cann, P., Bout, D. & Coursaget, P. (1997). Cell mediated immunity induced in mice by HPV 16 L1 virus-like particles. Microbial Pathogenesis 22, 219-225.
14. Frazer, I. H., Medley, G., Crapper, R. M., Brown, T. C. & Mackay, I. R. (1986). Association between anorectal dysplasia, human papillomavirus, and human immunodeficiency virus infection in homosexual men. Lancet ii, 657-660.
15. Hagensee, M. E., Yaegashi, N. & Galloway, D. A. (1993). Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. Journal of Virology 67, 315-322.
16. Jansen, K. U., Rosolowsky, M., Schultz, L. D., Markus, H. Z., Cook, J. C., Donnelly, J. J., Martinez, D., Ellis, R. W. & Shaw, A. R. (1995). Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation. Vaccine 13, 1509-1514.
17. Kent, S. J., Zhao, A., Best, S. J., Chandler, J. D., Boyle, D. B. & Ramshaw, I. A. (1998). Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus. Journal of Virology 72, 10180-10188.
18. Kirnbauer, R. (1996). Papillomavirus-like particles for serology and vaccine development. Intervirology 39, 54-61.
19. Kirnbauer, R., Booy, F., Cheng, N., Lowy, D. R. & Schiller, J. T. (1992). Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proceedings of the National Academy of Sciences, USA 89, 12180-12184.
20. Kirnbauer, R., Chandrachud, L M., O'Neil, B. W., Wagner, E. R., Grindlay, G. J., Armstrong, A., McGarvie, G. M., Schiller, J. T., Lowy, D. R. & Campo, M. S. (1996). Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization. Virology 219, 37-44.
21. Lowy, D. R., Kirnbauer, R. & Schiller, J. T. (1994). Genital human papillomavirus infection. Proceedings of the National Academy of Sciences, USA 91, 2436-2440.
22. NIH (1996). Cervical cancer. Consensus Statement no. 14, pp. 1-38.
23. O'Neill, H. C. & Brenan, M. (1987). A role for early cytotoxic T cells in resistance to ectromelia virus infection in mice. Journal of General Virology 68, 2669-2673.
24. Peng, S., Frazer, I. H., Fernando, G. J. & Zhou, J. (1998). Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway. Virology 240, 147-157.
25. Rose, R. C., Bonnez, W., Reichman, R. C. & Garcea, R. L. (1993). Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles. Journal of Virology 67, 1936-1944.
26. Rose, R. C., Reichman, R. C. & Bonnez, W. (1994 a). Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera. Journal of General Virology 75, 2075-2079.
27. Rose, R. C., Bonnez, W., Da Rin, C., McCance, D. J. & Reichman, R. C. (1994b). Serological differentiation of human papillomavirus types 11, 16 and 18 using recombinant virus-like particles. Journal of General Virology 75, 2445-2449.
28. Stannard, L. M., Marais, D., Kow, D. & Dumbell, K. R. (1998). Evidence for incomplete replication of a penguin poxvirus in cells of mammalian origin. Journal of General Virology 79, 1637-1646.
29. Suzich, J. A., Ghim, S. J., Palmer-Hill, F. J., White, W. I., Tamura, J. K., Bell, J. A., Newsome, J. A., Jenson, A. B. & Schlegel, R. (1995). Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proceedings of the National Academy of Sciences, USA 92, 11553-11557.
30. White, W. I., Wilson, S. D., Bonnez, W., Rose, R. C., Koenig, S. & Suzich, J. A. (1998). In vitro infection and type-restricted antibody-mediated neutralization of authentic human papillomavirus type 16. Journal of Virology 72, 959-964.
31. Zinkernagel, R. M., Cooper, S., Chambers, J., Lazzarini, R. A., Hengartner, H. & Arnheiter, H. (1990). Virus-induced autoantibody response to a transgenic viral antigen. Nature 345, 68-71.